Alzheimer's disease is the most common cause of severe mental deterioration (dementia) in the elderly. It has been estimated that 30% to 50% of people over 85 years old suffer from this condition. The cause of Alzheimer's is largely not known but many theories have been and continue to be investigated.
Alzheimer’s disease is a chronic, slowly progressive, gradual in onset, irreversible condition that destroys brain nerve cells and other structures in the central nervous system. People with Alzheimer’s disease slowly develop dementia —a loss of memory and intellectual and social skills that result in confusion, disorientation, and the inability to think, reason, and understand. The decline in cognition and memory results in activities of daily living to performed with increasing difficulty.
People with Alzheimer’s disease (and other dementias) can have symptoms that change significantly from day to day, usually getting worse but occasionally seeming to get better. However, people with Alzheimer’s disease do get worse over time, especially regarding memory loss (which is the most common initial symptom).
Common symptoms of Alzheimer's disease include:
Scientists know that Alzheimer’s disease is caused by damage to brain nerve cells, as well as a loss of certain chemicals that facilitate communication between nerve cells. What is still not clearly understood is why this damage occurs.
ease][5]
BrainAreas of the Brain Affected by Alzheimer's Disease |
Brain autopsies of Alzheimer's patients show two characteristic brain abnormalities:
It has been estimated that over 4 million Americans have Alzheimer’s disease and the total healthcare costs are estimated to be over $100 billion in the US alone. The number of patients with Alzheimer’s disease is expected to triple during the next 20 years as the baby boomer generation ages with an associated rise in the economic burden. In most cases, Alzheimer’s disease develops in people over the age of 65. Although, there is a rare, early-onset form of the disease that may strike people as young as 30. Nearly all people who have Down syndrome develop Alzheimer's disease if they live into their forties.
[What are the risk factors for Alzheimer’s disease?
What are the symptoms of Alzheimer’s disease?
How is Alzheimer’s disease diagnosed?
What are the treatments for Alzheimer’s disease?
Are there screening tests for Alzheimer’s disease?
How can I reduce my risk of Alzheimer’s disease?
[What questions should I ask my doctor?
Where can I get more information about Alzheimer’s disease?][15]
Also, there seems to exist a correlation between Lyme disease and Alzheimer's disease, possibly suggesting that the infectious agent responsible for an initial Lyme disease infection could later be implicated as a cause of Alzheimer's disease. (This is speculated after autopsy of some Alzheimer's patients showed a presence of Lyme spirochetes in the brain.)1
References:
Alzheimer’s Association website. Available at: http://www.alz.org/ .
Carrillo MC, Blackwell A, Hampel H, et al. Early risk assessment for Alzheimer's disease. Alzheimers Disease. 2009;5(2):182-196.
National Institute on Aging. National Institutes of Health website. Available at: http://www.nia.nih.gov/ .
Rolland Y, Abellan van Kan G, Vellas B. Healthy brain aging: role of exercise and physical activity. Clin Geriatr Med. 2010;26(1):75-87.
9/18/2009 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Anstey KJ, Mack HA, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17:542-555.
8/23/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ.2010;341:c3885.
Because the causes are unknown, there are currently no guidelines for reducing your risk of Alzheimer’s disease . Scientists are studying medicines and lifestyle factors (eg, diet, mental activity, exercise, stress reduction) that may help ward off the condition. Control of high blood pressure, high cholesterol, and diabetes may also help to reduce your risk. Other studies have found that drinking alcohol in moderation (one drink per day for women, two drinks per day for men) may be beneficial, as well. In addition, some researchers have argued that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) can lower the risk.
Earlier studies indicated that hormone replacement therapy (HRT) in women decreased the risk of developing Alzheimer’s disease. However, recent studies showed that HRT may actually increase the risk of Alzheimer’s disease in postmenopausal women. As our understanding of Alzheimer’s disease grows, your doctor may have more information regarding steps for reducing your risk as you age.
There is some evidence that exercise may decrease the risk of dementia.
Address:
PO Box 8250
Silver Spring, MD 20907-8250
Phone:
1-800-438-4380
Internet address:
http://www.nia.nih.gov/alzheimers/
Description of services provided:
This site is part of the National Institute on Aging. It provides information and referral service, news and research information, publications, multimedia, and links to other resources.
Address:
Alzheimer’s Association
225 N Michigan Ave, Fl 17
Chicago, IL 60601-7633
Phone:
1-800-272-3900
1-312-335-8700
Internet address:
http://www.alz.org/
Description of services provided:
This association is a network of national chapters. The organization funds Alzheimer’s research and provides research, educational, and support information to patients, family, caregivers, and professionals.
Address:
Alzheimer’s Foundation of America
322 8th Avenue, 7th Floor
New York, NY 10001
Phone:
1-866-232-8484
Internet address:
http://www.alzfdn.org/
Description of services provided:
This website provides information about services for those with dementia, as well as information for their caregivers and families.
Address:
NIH Neurological Institute
PO Box 5801
Bethesda, MD 20824
Phone:
1-800-352-9424
Internet address:
http://www.ninds.nih.gov/index.htm/
Description of services provided:
NINDS provides educational, news, and research information for consumers and health professionals on various neurological conditions, including Alzheimer’s disease.
The purpose of screening is early diagnosis and treatment. Screening tests are usually administered to people without any current symptoms, but who may be at high risk for certain diseases or conditions.
There are several tests that doctors may use to screen for Alzheimer's disease . Examples include:
Genetic testing is available, but it is not routinely used in most patients. Researchers are also studying whether imaging tests would be helpful in screening for Alzheimer's disease.
You have a unique medical history. Therefore, it is essential to talk with your doctor about your personal risk factors and/or experience with Alzheimer’s disease. By talking openly and regularly with your doctor, you can take an active role in your care.
General Tips for Gathering Information
Here are some tips that will make it easier for you to talk to your doctor:
Specific Questions to Ask Your Doctor
About Your Risk of Developing Alzheimer’s Disease
About a Diagnosis of Alzheimer’s Disease
About Treatment Options
About Lifestyle Changes
About Your Outlook
References:
Alzheimer’s Association website. Available at: http://www.alz.org/ .
Alzheimer's disease is the most common cause of severe mental deterioration (dementia) in the elderly. It has been estimated that 30% to 50% of people over 85 years old suffer from this condition. The cause of Alzheimer's is largely not known but many theories have been and continue to be investigated.
Alzheimer’s disease is a chronic, slowly progressive, gradual in onset, irreversible condition that destroys brain nerve cells and other structures in the central nervous system. People with Alzheimer’s disease slowly develop dementia —a loss of memory and intellectual and social skills that result in confusion, disorientation, and the inability to think, reason, and understand. The decline in cognition and memory results in activities of daily living to performed with increasing difficulty.
People with Alzheimer’s disease (and other dementias) can have symptoms that change significantly from day to day, usually getting worse but occasionally seeming to get better. However, people with Alzheimer’s disease do get worse over time, especially regarding memory loss (which is the most common initial symptom).
Common symptoms of Alzheimer's disease include:
Scientists know that Alzheimer’s disease is caused by damage to brain nerve cells, as well as a loss of certain chemicals that facilitate communication between nerve cells. What is still not clearly understood is why this damage occurs.
Areas of the Brain Affected by Alzheimer's Disease |
Brain autopsies of Alzheimer's patients show two characteristic brain abnormalities:
It has been estimated that over 4 million Americans have Alzheimer’s disease and the total healthcare costs are estimated to be over $100 billion in the US alone. The number of patients with Alzheimer’s disease is expected to triple during the next 20 years as the baby boomer generation ages with an associated rise in the economic burden. In most cases, Alzheimer’s disease develops in people over the age of 65. Although, there is a rare, early-onset form of the disease that may strike people as young as 30. Nearly all people who have Down syndrome develop Alzheimer's disease if they live into their forties.
What are the risk factors for Alzheimer’s disease?
What are the symptoms of Alzheimer’s disease?
How is Alzheimer’s disease diagnosed?
What are the treatments for Alzheimer’s disease?
Are there screening tests for Alzheimer’s disease?
How can I reduce my risk of Alzheimer’s disease?
What questions should I ask my doctor?
Where can I get more information about Alzheimer’s disease?
Also, there seems to exist a correlation between Lyme disease and Alzheimer's disease, possibly suggesting that the infectious agent responsible for an initial Lyme disease infection could later be implicated as a cause of Alzheimer's disease. (This is speculated after autopsy of some Alzheimer's patients showed a presence of Lyme spirochetes in the brain.)1
References:
Alzheimer’s Association website. Available at: http://www.alz.org/ .
National Institute on Aging, National Institutes of Health website. Available at: http://www.nia.nih.gov/ .
References:
Alzheimer’s Association website. Available at: http://www.alz.org/ .
Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov.2010;9(7):560-574.
References:
Alzheimer's disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated March 2009. Accessed April 1, 2009.
Dementia. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated November 2009. Accessed November 6, 2009.
Risk factor. Alzheimer’s Association website. Available at: http://www.alz.org/ . Accessed April 1, 2009.
8/23/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ.2010;341:c3885.
Alzheimer’s disease progresses slowly, and changes take place gradually over time. People can live with Alzheimer’s disease for 3-25 years, although the average duration of the disease is about 8-10 years. In general, changes can be characterized in three phases.
Subtle changes occur, but the problem is sometimes hard to pinpoint. More often, family members recognize these changes rather than the patients themselves. Common changes may include:
Impairments in memory and mental functioning become more obvious. Long-term memory may still be intact, but short-term memory fails. Other changes include:
Abilities decline dramatically. Changes include:
A risk factor is something that increases your likelihood of getting a disease or condition.
It is possible to develop Alzheimer’s disease with or without the risk factors listed below. However, the more risk factors you have, the greater your likelihood of developing Alzheimer’s disease.
There are still many questions regarding the exact cause of Alzheimer’s disease, so risk factors are still being identified. Currently, risk factors for Alzheimer’s disease include:
Age
Age is the most important known risk factor for developing Alzheimer’s disease. The number of people with Alzheimer’s disease doubles every five years beyond age 65 until age 85, when almost 50% of all people have the disease.
Gender
Alzheimer’s disease affects both men and women, but women may have a slightly higher risk of developing the disease than men. Some experts believe that this is due to the fact that women live longer than men, but others dispute this claim.
Genetic Factors
Individuals with a first-degree relative of someone with Alzheimer’s disease (a parent or sibling) have a two- to three-times risk of developing the disease when compared to the rest of the population. In addition, there has been a clear genetic link established for an early-onset form of Alzheimer’s disease (occurs in people during their 30s, 40s, and early 50s), and a genetic link is suspected for late-onset Alzheimer’s disease. However, a specific gene has not yet been identified. One gene that has been implicated as being a major risk factor for late-onset Alzheimer’s disease is the ApoE4 gene. Scientists continue to study the role of genetic factors in the development of this disease.
Medical Conditions
Mental Activity and Education
Some research has suggested that people who have higher education levels and continue to be mentally active and engaged in their later years are less likely to develop Alzheimer’s disease. However, some experts suggest that this finding may actually be due to the fact that those with higher education levels tend to do better on the psychological tests used to diagnose Alzheimer’s.
Environment
Some theories suggest that Alzheimer’s disease may be linked to exposure to certain environmental factors, such as toxins, certain viruses and bacteria, certain metals, or electromagnetic fields. Currently, there is no conclusive evidence to support these theories.
There are no laboratory tests to confirm a diagnosis of Alzheimer's disease. However, your doctor will be able do a thorough clinical evaluation and conduct tests that will provide a diagnosis with a relatively high accuracy rate, and other potential conditions will be ruled out.
Initially, the doctor will ask about your symptoms and medical history, and perform a physical exam. Tests to rule out other conditions may include:
This may be done to rule out other causes of dementia. These tests may include:
Genetic tests are being offered for people with family members with early-onset Alzheimer’s.
Though not routine, a lumbar puncture (spinal tap) to test the cerebrospinal fluid (CSF) and an ophthalmologic screening can be done to investigate for other atypical causes of dementia. Additionally, electroencephalogram (EEG) is a test that evaluates and follows the electrical activity of the brain. This is not a routine test for evaluating dementia.
A diagnosis of Alzheimer’s disease usually falls into one of three categories:
References:
Alzheimer’s Association website. Available at: http://www.alz.org/ .
Alzheimer's disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated June 2009. Accessed July 6, 2009.
Hampel H, et al. Biomarker’s for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560-74.
Wolk DA, Klunk W. Update on amyloid imaging: from healthy aging to Alzheimer's disease. Curr Neurol Neurosci Rep. 2009;9(5):345-352.
7/6/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed/what.php : Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ. 2009;338:b2030.